BIO Industry Analysis Investor Survey: FDA Approvals Expected to Increase and Majority of Investors Believe Now Is a Good Time to Invest in Biotech

WASHINGTON--(BUSINESS WIRE)--The BIO CEO & Investor Conference wrapped up in NYC yesterday amidst renewed optimism among investors and signs that FDA approvals may be on the rise in 2012, according to BIO Industry Analysis data.

Feed Date: 
Wed, 2012-02-15 17:05